Pharmacy

Community pharmacists are rallying behind a federal bill reintroduced last fall that would require drug manufacturers to provide printed medication information with every outpatient prescription. Reps. Cliff Bentz, R-Ore., and Jared Golden, D-Maine, reintroduced the Patients’ Right to Know Their…

The FDA recently sent a warning letter to Novo Nordisk, raising concerns about the drug company failing to report adverse drug events.  The letter, dated March 5, outlines the FDA’s observations at the drug company’s site in Plainsboro, N.J., during…

As a pharmacy leader, you feel the pinch of vacancies in the day-to-day. You see it in the schedule, the queue, and the strain on your strongest people. You know the cost of labor, but are you measuring the financial…

An oncology pharmacy leader at Memorial Healthcare System in Hollywood, Fla., has joined Ascension St. John Medical Center in Tulsa, Okla., as director of oncology and infusion services.  Vince Sung, PharmD, announced his role change in a March 10 LinkedIn…

Ipsen, a Paris-based drugmaker, is removing its cancer drug Tazverik (tazemetostat) from the U.S. market because of safety concerns.  An ongoing Tazverik clinical trial has reported adverse events of secondary hematologic malignancies — which are blood cancers — indicating “the…

A March 9 draft guidance from the FDA proposes an allowance for biosimilar sponsors to use clinical data from outside the U.S. to seek the agency’s approval, which would reduce the requirement of at least one study in the approval…

Children’s Hospital Los Angeles has expanded its cell and gene therapy program to include 12 FDA-approved therapies.  The program now offers more cell and gene therapies than any pediatric center on the West Coast, according to a March 5 news…

Statista, a global data company that publishes insights for 170 industries, projects four cancer therapies will be among the top 10 best-selling pharmaceutical products in the U.S. this year.  The company projects Merck’s cancer drug Keytruda will earn $12.7 billion…

Eli Lilly’s Mounjaro is projected to be the best-selling drug in the world in 2030, according to Statista data shared March 9 with Becker’s.  Statista is a global data company that provides market insights for 170 industries, including pharmaceuticals.  The…

The FDA recently met with several states to discuss the Section 804 Importation Program, which allows states and tribes to propose plans to import certain lower-cost prescription drugs from Canada. The meeting — held with representatives from HHS and the…